4//SEC Filing
PetLife Pharmaceuticals, Inc. 4
Accession 0001493152-17-002849
CIK 0001354591operating
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 7:47 PM ET
Size
13.1 KB
Accession
0001493152-17-002849
Insider Transaction Report
Form 4
Campbell Vyvyan
Director10% Owner
Transactions
- Award
Common Stock
2016-10-27$0.50/sh+1,200,000$600,000→ 1,568,680 total - Purchase
Common Stock
2015-05-30$0.75/sh+50,210$37,658→ 50,210 total - Purchase
Common Stock
2015-11-09$0.25/sh+100,000$25,000→ 150,210 total - Purchase
Common Stock
2016-05-15$1.25/sh+218,470$273,088→ 368,680 total - Purchase
Common Stock
2017-02-23$0.25/sh+40,000$10,000→ 1,608,680 total - Award
Common Stock
2017-02-23$0.50/sh+9,484,555$4,742,278→ 9,484,555 total(indirect: By Trust)
Footnotes (3)
- [F1]Adjusted for the issuer's 1-for-5 reverse stock split effected in September 2016.
- [F2]For services valued at $0.50/share.
- [F3]Ms. Campbell is the trustee of the trust and has sole voting and dispositive power with respect to shares held in the name of the trust.
Documents
Issuer
PetLife Pharmaceuticals, Inc.
CIK 0001354591
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001354591
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 7:47 PM ET
- Size
- 13.1 KB